Rolf Barth to Prospective Studies
This is a "connection" page, showing publications Rolf Barth has written about Prospective Studies.
Connection Strength
0.104
-
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts. Clin Transplant. 2019 06; 33(6):e13531.
Score: 0.090
-
Living kidney donor relationship in Caucasian and African American populations and implications for targeted donor education programs. Clin Transplant. 2013 Jan-Feb; 27(1):32-6.
Score: 0.014